Enomoto Yasunori, Takemura Tamiko, Hagiwara Eri, Iwasawa Tae, Okudela Koji, Yanagawa Noriyo, Baba Tomohisa, Sakai Fumikazu, Fukuda Yuh, Nagaoka Shouhei, Ogura Takashi
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomioka-Higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Department of Pathology, Japanese Red Cross Medical Center, 4-1-22, Hiroo, Shibuya-ku, Tokyo 150-8935, Japan.
Respir Investig. 2014 Jul;52(4):227-35. doi: 10.1016/j.resinv.2014.02.003. Epub 2014 Apr 13.
The different characteristics of usual interstitial pneumonia in patients with primary Sjögren׳s syndrome (UIP/pSS) compared with idiopathic pulmonary fibrosis (UIP/IPF) are not fully understood. This study aimed to compare characteristics, prognosis, and treatment responses in these patients.
Among 129 consecutive patients who underwent surgical lung biopsy to diagnose diffuse lung diseases at Kanagawa Cardiovascular and Respiratory Center between 1998 and 2002, we identified 10 and 19 patients with UIP/pSS and UIP/IPF, respectively. Baseline characteristics, chest high-resolution computed tomography (HRCT) and pathological findings, and the clinical course were compared between the two groups. Responses to immunosuppressive therapy were analyzed by comparing pulmonary function and clinical status before and one year after treatment initiation.
More patients in the UIP/pSS group tended to be female and older than those in the UIP/IPF group (mean age, 68 years vs. 62 years). In addition, they more commonly exhibited enlarged mediastinal lymph nodes and bronchial wall thickening on HRCT. Pathologically, in the UIP/pSS group, interstitial inflammation, plasma cell infiltration, lymphoid follicles with germinal centers, cysts, bronchiolitis, and pleuritis were significantly more prominent, whereas smooth muscle hyperplasia and fibroblastic foci were milder (all P<0.05). The prognosis was better for UIP/pSS compared with UIP/IPF patients (P=0.01). In addition, immunosuppressive therapy provided better disease control for those with UIP/pSS (83%, 5/6) compared UIP/IPF (7%, 1/15).
This study identified distinct clinical, radiological, and pathological characteristics of UIP/pSS compared with UIP/IPF. Immunosuppressive treatment could be a therapeutic option for UIP/pSS.
与特发性肺纤维化(UIP/IPF)相比,原发性干燥综合征患者的普通型间质性肺炎(UIP/pSS)的不同特征尚未完全明确。本研究旨在比较这些患者的特征、预后及治疗反应。
在1998年至2002年间于神奈川心血管和呼吸中心接受外科肺活检以诊断弥漫性肺疾病的129例连续患者中,我们分别确定了10例UIP/pSS患者和19例UIP/IPF患者。比较两组患者的基线特征、胸部高分辨率计算机断层扫描(HRCT)及病理结果,以及临床病程。通过比较治疗开始前及开始后一年的肺功能和临床状况,分析免疫抑制治疗的反应。
UIP/pSS组女性患者多于UIP/IPF组,且年龄更大(平均年龄分别为68岁和62岁)。此外,UIP/pSS组患者在HRCT上更常表现为纵隔淋巴结肿大和支气管壁增厚。病理上,UIP/pSS组的间质炎症、浆细胞浸润、有生发中心的淋巴滤泡、囊肿、细支气管炎和胸膜炎更为显著,而平滑肌增生和成纤维细胞灶则较轻(所有P<0.05)。与UIP/IPF患者相比,UIP/pSS患者的预后更好(P=0.01)。此外,与UIP/IPF患者(7%,1/15)相比,免疫抑制治疗对UIP/pSS患者(83%,5/6)的疾病控制效果更好。
本研究明确了UIP/pSS与UIP/IPF在临床、影像学和病理特征上的差异。免疫抑制治疗可能是UIP/pSS的一种治疗选择。